BIOTECHNOLOGY VALUE FUND

biotechnology-value-fund-logo

Biotechnology Value Fund is a San Francisco-based private investment partnership specializing in fundamentally-driven public biotechnology investments. Since its inception in 1993, BVF has strived to build concentrated, long-term investments in small-cap biotechnology companies while performing rigorous diligence and on-going monitoring of its investments. BVF is committed to working with its portfolio companies as partners in their successes.

#SimilarOrganizations #People #Financial #More

BIOTECHNOLOGY VALUE FUND

Industry:
Biotechnology Venture Capital

Founded:
1993-01-01

Status:
Active

Contact:
(312)506-6479

Email Addresses:
[email protected]

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon WordPress PHP PHP 7 Twemoji OpenResty


Similar Organizations

atlas-venture-logo

Atlas Venture

Atlas Venture creates and invests in biotech startup companies with seed and early stage venture investments.

azure-capital-partners-logo

Azure Capital Partners

Azure Capital Partners is a venture capital firm specializing in early-stage and growth capital investments.

bioadvance-logo

BioAdvance

BioAdvance is a Pennsylvania-based venture capital firm that provides funding to life sciences startups.

Current Employees Featured

matthew-perry_image

Matthew Perry
Matthew Perry Portfolio Manager @ Biotechnology Value Fund
Portfolio Manager
1996-12-01

gorjan-hrustanovic_image

Gorjan Hrustanovic
Gorjan Hrustanovic Managing Director @ Biotechnology Value Fund
Managing Director
2020-12-01

spike-loy_image

Spike Loy
Spike Loy Managing Director @ Biotechnology Value Fund
Managing Director
2009-09-01

sam-huang_image

Sam Huang
Sam Huang Principal @ Biotechnology Value Fund
Principal
2018-07-01

michael-murray_image

Michael Murray
Michael Murray Analyst @ Biotechnology Value Fund
Analyst

kanishka-pothula_image

Kanishka Pothula
Kanishka Pothula Managing Director @ Biotechnology Value Fund
Managing Director
2012-03-01

mitchell-kaye_image

Mitchell Kaye
Mitchell Kaye Business & Operations @ Biotechnology Value Fund
Business & Operations
2013-09-01

james-kratky_image

James Kratky
James Kratky Chief Financial Officer, Chief Compliance Officer @ Biotechnology Value Fund
Chief Financial Officer, Chief Compliance Officer
2017-05-01

Investments List

Date Company Article Money raised
2022-08-19 Kymera Therapeutics Biotechnology Value Fund investment in Post-IPO Equity - Kymera Therapeutics 150 M USD
2021-07-13 Nimbus Therapeutics Biotechnology Value Fund investment in Venture Round - Nimbus Therapeutics 105 M USD
2021-04-08 Ventus Therapeutics Biotechnology Value Fund investment in Series B - Ventus Therapeutics 100 M USD
2021-03-30 Pyxis Oncology Biotechnology Value Fund investment in Series B - Pyxis Oncology 152 M USD
2020-12-28 Gritstone Bio Biotechnology Value Fund investment in Post-IPO Equity - Gritstone Bio 125 M USD
2020-07-22 Olema Oncology Biotechnology Value Fund investment in Series B - Olema Oncology 54 M USD
2020-06-11 Autobahn Therapeutics Biotechnology Value Fund investment in Series B - Autobahn Therapeutics 76 M USD
2020-05-20 Surface Oncology Biotechnology Value Fund investment in Post-IPO Equity - Surface Oncology 28.9 M USD
2020-03-12 Kymera Therapeutics Biotechnology Value Fund investment in Series C - Kymera Therapeutics 102 M USD
2020-01-31 Syndax Pharmaceuticals Biotechnology Value Fund investment in Post-IPO Debt - Syndax Pharmaceuticals 30 M USD

More informations about "Biotechnology Value Fund"

Biotechnology Value Fund - Investments, Portfolio & Company Exits

Biotechnology Value Fund has made 27 diversity investments. Their most recent diversity โ€ฆSee details»

Hedge Fund - Biotechnology Value Fund / BVF Inc - Insider Monkey

Jul 24, 2017 Established in 1993, Biotechnology Value Fund is a private investment โ€ฆSee details»

Biotechnology Value Fund Portfolio Companies - Crunchbase

Biotechnology Value Fund is an evergreen fund specializing in early stage financing. It focuses โ€ฆSee details»

Biotechnology Value Fund (BVF Partners) - Golden

BVF Partners L.P. is a San Francisco-based private investment partnership specializing in โ€ฆSee details»

Biotechnology Value Fund - Massinvestor Venture Capital and โ€ฆ

Biotechnology Value Fund (BVF Partners) is a San Francisco-based private investment โ€ฆSee details»

Biotechnology Value Fund LP - AUM 13F

Fund Details; Director: BVF I GP LLC, BVF Partners LP: Custodian: The Bank of New York โ€ฆSee details»

Biotechnology Value Fund Investment Information | CipherBio

Find out which companies Biotechnology Value Fund is investing in, as well as the disease โ€ฆSee details»

Mark Lampert - Lifeline Fund

Mark Lampert is the founder and president of the Biotechnology Value Fund, L.P., a San โ€ฆSee details»

Small-Cap, Biotech-Focused Hedge Fund BVF's Top Q3 Picks

Dec 28, 2011 San Francisco-based Biotechnology Value Fund Partners (BVF), with $250 โ€ฆSee details»

Biotechnology Value Fund L P Now Owns 9.60% of Protagonist

Fintel reports that Biotechnology Value Fund L P has filed a 13G form with the SEC disclosing โ€ฆSee details»

Biotechnology Value Fund - Funding, Financials, Valuation

Biotechnology Value Fund has raised a single venture fund, Biotechnology Value Fund II. โ€ฆSee details»

Institutional Top Ideas: Biotechnology Value Fund โ€ฆ

Prior Entries in This Series#1: Baker Brothers#2: EcoR1 Capital#3: Deep Track Capital#4: โ€ฆSee details»

Institutional Top Ideas Series: Biotechnology Value Fund

Jun 4, 2018 Possible 1 Sentence Thesis: Recently announced strategic plans appear to have โ€ฆSee details»

7 Best Biotech ETFs to Buy Now | Investing | U.S. News

Jun 28, 2024 A great example is IBB, which tracks 215 holdings represented by the NYSE โ€ฆSee details»

Backgrounder โ€“ Government of Canada investments in COVID-19 โ€ฆ

Feb 2, 2021 $600 million through the Strategic Innovation Fund to support COVID-19 vaccine โ€ฆSee details»

Biotechnology Value Fund - Contacts, Employees, Board

Biotechnology Value Fund has 8 current employee profiles, including Portfolio Manager โ€ฆSee details»

7 Best-Performing Biotech ETFs for November 2024 - NerdWallet

Nov 3, 2024 For example, shares of biopharmaceutical company Amgen Inc. make up (as of โ€ฆSee details»

Whatโ€™s ahead for biotech: Another wave or low tide? - McKinsey

Apr 30, 2021 The value of codevelopments, partnerships, joint ventures, licensing โ€ฆSee details»

Fidelity Select Biotechnology Fund Stock Price - Morningstar

Sep 30, 2024 Fidelity Select Biotechnology Portfolio earns an Above Average Process Pillar โ€ฆSee details»

linkstock.net © 2022. All rights reserved